TrialJAMA psychiatry2022

Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.

Edna B Foa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.